ALLOGENEIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a sweetener stop deadly infections in transplant kids?
Disease control OngoingThis study tests whether a special wipe containing xylitol, a natural sweetener, can reduce dangerous bloodstream infections in children and young adults undergoing stem cell transplants. These infections often start from bacteria in the mouth and can be life-threatening. Partici…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Promising cancer drug trial pulled before it even started
Disease control TerminatedThis trial aimed to test the drug ASTX727 (Inqovi) alone or with donor immune cells in people with blood cancers who had a stem cell transplant. The goal was to see if it could control cancer that remained or came back. However, the study was withdrawn before enrolling any patien…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for older leukemia patients: drug may keep cancer away after transplant
Disease control OngoingThis phase 2 study tests whether the drug ruxolitinib can help prevent acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) from coming back after a stem cell transplant. About 64 older adults in remission will take ruxolitinib as maintenance therapy. The goal is to see…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC